Hengkang Medical Group Co., Ltd.
SZSE:002219.SZ
3.12 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 3,568.367 | 3,152.735 | 3,016.071 | 2,805.895 | 3,684.468 | 3,838.392 | 3,399.324 | 2,175.221 | 1,181.728 | 685.658 | 564.725 | 336.964 | 307.245 | 299.332 | 285.116 | 284.973 | 198.232 | 130.103 | 100.225 | 83.973 |
| Cost of Revenue
| 2,579.771 | 2,160.096 | 2,208.358 | 2,015.146 | 2,711.949 | 3,011.805 | 2,317.7 | 1,392.104 | 628.271 | 274.276 | 174.653 | 126.315 | 107.027 | 108.867 | 119.121 | 129.313 | 101.987 | 79.986 | 59.029 | 45.502 |
| Gross Profit
| 988.596 | 992.639 | 807.713 | 790.75 | 972.519 | 826.587 | 1,081.624 | 783.117 | 553.457 | 411.382 | 390.073 | 210.65 | 200.218 | 190.465 | 165.995 | 155.66 | 96.245 | 50.117 | 41.196 | 38.471 |
| Gross Profit Ratio
| 0.277 | 0.315 | 0.268 | 0.282 | 0.264 | 0.215 | 0.318 | 0.36 | 0.468 | 0.6 | 0.691 | 0.625 | 0.652 | 0.636 | 0.582 | 0.546 | 0.486 | 0.385 | 0.411 | 0.458 |
| Reseach & Development Expenses
| 27.71 | 0.238 | 0.444 | 0.297 | 1.293 | 8.268 | 0.448 | 1.011 | 7.73 | 8.802 | 9.371 | 8.499 | 9.593 | 8.718 | 0 | 2.499 | 2.155 | 0 | 0 | 0 |
| General & Administrative Expenses
| 234.341 | 86.052 | 114.59 | 80.105 | 215.308 | 134.78 | 95.721 | 41.621 | 23.814 | 13.99 | 8.894 | 8.706 | 6.341 | 8.524 | 30.864 | 11.147 | 13.384 | 12.199 | 10.383 | 12.138 |
| Selling & Marketing Expenses
| 206.823 | 287.006 | 283.85 | 226.04 | 250.73 | 195.741 | 84.944 | 58.081 | 16.217 | 9.862 | 110.661 | 94.498 | 92.795 | 84.469 | 80.97 | 81.008 | 41.429 | 14.19 | 10.854 | 10.801 |
| SG&A
| 833.732 | 373.058 | 398.44 | 306.145 | 466.037 | 330.521 | 180.665 | 99.702 | 40.031 | 23.852 | 119.555 | 103.205 | 99.136 | 92.993 | 111.833 | 92.155 | 54.813 | 26.389 | 21.237 | 22.939 |
| Other Expenses
| -0.402 | 318.102 | 322.538 | 258.537 | 384.353 | -37.005 | 7.087 | 32.691 | 72.759 | 32.155 | 3.733 | 11.551 | 9.806 | 6.355 | 3.368 | 7.488 | 2.026 | 2.961 | 2.669 | 0.05 |
| Operating Expenses
| 861.844 | 691.398 | 721.423 | 564.978 | 851.683 | 784.415 | 527.172 | 263.47 | 130.846 | 85.417 | 174.429 | 128.991 | 122.838 | 115.054 | 112.955 | 104.589 | 57.075 | 26.816 | 21.81 | 23.321 |
| Operating Income
| 126.752 | 358.04 | 153.95 | 198.098 | 120.836 | -1,296.902 | 298.724 | 430.025 | 328.061 | 282.123 | 201.02 | 76.479 | 74.365 | 72.754 | 53.231 | 45.778 | 37.84 | 21.255 | 18.798 | 13.679 |
| Operating Income Ratio
| 0.036 | 0.114 | 0.051 | 0.071 | 0.033 | -0.338 | 0.088 | 0.198 | 0.278 | 0.411 | 0.356 | 0.227 | 0.242 | 0.243 | 0.187 | 0.161 | 0.191 | 0.163 | 0.188 | 0.163 |
| Total Other Income Expenses Net
| -116.467 | -170.557 | -516.339 | -188.107 | -2,557.84 | -1,376.079 | -248.642 | -58.064 | -22.071 | -35.628 | -11.328 | 3.34 | 5.571 | 2.239 | 3.116 | 2.041 | 1.271 | -0.624 | 0.792 | -1.421 |
| Income Before Tax
| 10.284 | 187.484 | -362.389 | 9.991 | -2,437.004 | -1,333.907 | 305.81 | 461.583 | 400.54 | 290.337 | 204.316 | 84.998 | 82.95 | 77.65 | 56.155 | 53.111 | 40.44 | 22.677 | 20.179 | 13.729 |
| Income Before Tax Ratio
| 0.003 | 0.059 | -0.12 | 0.004 | -0.661 | -0.348 | 0.09 | 0.212 | 0.339 | 0.423 | 0.362 | 0.252 | 0.27 | 0.259 | 0.197 | 0.186 | 0.204 | 0.174 | 0.201 | 0.163 |
| Income Tax Expense
| -28.655 | 23.183 | 4.914 | 52.504 | 60.506 | 53.775 | 83.105 | 65.415 | 78.43 | 33.188 | 32.99 | 12.055 | 11.605 | 11.688 | 8.35 | 8.6 | 6.644 | 3.419 | 2.6 | 0.72 |
| Net Income
| 30.777 | 156.122 | -367.303 | -42.513 | -2,497.51 | -1,417.818 | 202.809 | 403.631 | 323.626 | 257.333 | 169.827 | 73.672 | 71.346 | 65.961 | 47.805 | 44.511 | 33.797 | 19.258 | 17.578 | 13.729 |
| Net Income Ratio
| 0.009 | 0.05 | -0.122 | -0.015 | -0.678 | -0.369 | 0.06 | 0.186 | 0.274 | 0.375 | 0.301 | 0.219 | 0.232 | 0.22 | 0.168 | 0.156 | 0.17 | 0.148 | 0.175 | 0.163 |
| EPS
| 0.009 | 0.048 | -0.2 | -0.023 | -1.34 | -0.76 | 0.11 | 0.21 | 0.19 | 0.17 | 0.11 | 0.049 | 0.048 | 0.044 | 0.032 | 0.049 | 0.048 | 0.039 | 0.035 | 0.027 |
| EPS Diluted
| 0.009 | 0.048 | -0.2 | -0.023 | -1.34 | -0.76 | 0.11 | 0.21 | 0.19 | 0.17 | 0.11 | 0.049 | 0.048 | 0.044 | 0.032 | 0.049 | 0.048 | 0.039 | 0.035 | 0.027 |
| EBITDA
| 365.404 | 524.561 | 317.239 | 368.752 | -224.985 | 38.541 | 801.313 | 663.956 | 587.231 | 374.843 | 262.931 | 121.244 | 108.236 | 97.197 | 59.989 | 64.439 | 42.958 | 28.883 | 24.836 | 19.834 |
| EBITDA Ratio
| 0.102 | 0.166 | 0.105 | 0.131 | -0.061 | 0.01 | 0.236 | 0.305 | 0.497 | 0.547 | 0.466 | 0.36 | 0.352 | 0.325 | 0.21 | 0.226 | 0.217 | 0.222 | 0.248 | 0.236 |